Abbott Laboratories has retained a $33.4 million sanctions award after the U.S. Court of Appeals for the Second Circuit ruled that a medical product wholesaler, along with its CEO and his wife, waived their right to a jury trial in this trademark infringement lawsuit. Instead, the parties agreed to a damages inquest, precluding a trial over the imposed sanctions.
The litigation centered on allegations of repeated discovery abuses and misrepresentations made to the court by H&H Wholesale Services Inc. The appellate court’s summary order affirmed the lower court’s findings, concluding that lesser sanctions would have been ineffective given the severity and recurrence of the defendants’ conduct.
The Second Circuit’s decision underscores the judiciary’s intolerance of discovery-related misconduct and emphasizes the importance of adherence to procedural rules. The judgment also serves as a cautionary tale for legal professionals involved in complex litigation, highlighting the potential consequences of failing to comply with discovery obligations.
For further details, the ruling can be reviewed in the summary order issued by the U.S. Court of Appeals for the Second Circuit.